Bavarian Nordic is successfully navigating a sentiment-changing vaccine landscape, posting Q1 revenues significantly up from ...

Nordic Pharma, a subsidiary of Nordic Group B.V., announced a partnership with Harrow, a leading North American eyecare company, to launch an authorized generic of Maxitrol (neomycin and polymyxin ...

BERWYN, Pa., April 24, 2025 /PRNewswire/ -- Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., announced a partnership with Harrow (Nasdaq: HROW), a leading ...

LOS ANGELES — Nordic Pharma and Harrow partnered to launch an authorized generic of Maxitrol, Nordic President Philip Gioia said in this Healio Video Perspective from SightLine. Gioia said the ...

On the 7th, JEIL PHARMACEUTICAL's subsidiary Onconic Therapeutics announced that its gastroesophageal reflux disease treatment 'Ja Q Bo' will expand into five Nordic countries. According to ...

Denmark's business minister criticized U.S. President Trump's executive order mandating lower drug prices, highlighting the ...

The UK MHRA has granted marketing authorisation to Bavarian Nordic's Vimkunya vaccine for preventing the chikungunya virus.

BERWYN, PA — Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., is set to present groundbreaking data on its LACRIFILL® Canalicular Gel during the American Society of Cataract and ...

OSLO, Norway, April 30, 2025 /PRNewswire/ -- In the first quarter of 2025, Navamedic ASA (OSE: NAVA), a Nordic pharma company and trusted supplier of high-quality prescription, consumer health ...

Denmark’s economic growth, which was driven by what economists described as an “exceptional surge” in pharmaceutical exports, ...